"
Team:Paris/Addressing overview Construction
From 2009.igem.org
(Difference between revisions)
(→Construction) |
(→Construction) |
||
| Line 82: | Line 82: | ||
Here the activation of our construction '''by arabinose'''. | Here the activation of our construction '''by arabinose'''. | ||
| - | <br> It is quite the same as the first construction but in [http://www.ncbi.nlm.nih.gov/pubmed/18511069[1]] | + | <br> It is quite the same as the first construction, but in [http://www.ncbi.nlm.nih.gov/pubmed/18511069[1]] the RFP-Cter link to Nter-ClyA seems to have a better fluorescence. Because of our late about receiving the oligo for its synthesis in biobrick format, we used the first construction (ClyA-Cter link to Nter-RFP). |
Revision as of 23:29, 21 October 2009
iGEM > Paris > ClyA > Construction
Construction
Here the activation of our construction by arabinose, in order to test the construction.
Here the inhibition of our construction by glucose, in order to test the construction.
Here the activation of our construction by arabinose.
It is quite the same as the first construction, but in [1] the RFP-Cter link to Nter-ClyA seems to have a better fluorescence. Because of our late about receiving the oligo for its synthesis in biobrick format, we used the first construction (ClyA-Cter link to Nter-RFP).
Bibliography :
[1] Kim, J.-Y. & DeLisa, M.P. Engineered bacterial outer membrane vesicles with enhanced functionality J.Mol. Biol. (2008) 380, 51–66
